Abstract

References
1.
Kenemans
P
,
Bast
R
,
Yedema
C
,
Price
M
,
Hilgers
J.
CA 125 and polymorphic epithelial mucin as serum tumor markers . Cancer Rev
1988 ; 11/12 : 119 –44
2.
Pabst
T
,
Ludwig
C.
CA-125: A tumor marker in Non-Hodgkin's lymphomas?
J Clin Oncol
1995 ; 13 : 1827 –8
3.
Pabst
T
,
Ludwig
Ch
. CA-125 — a tumour marker? [in German]
Schweiz Med Wochenschr
1995 ; 125 : 1195 –200
4.
Ravoet
C
,
Dargent
J-L
,
Le Moine
L
,
Feremans
W.
CA-125 in primary mediastinal B-cell lymphoma with sclerosis . J Clin Oncol
1995 ; 13 : 530 –1
5.
Buhl
CH
,
Füllbrandt
U
,
Pompecki
R
,
Frenzel
H.
CA-125 and CA 19-9 in non-Hodgkin's lymphoma [in German] . Dtsch Med Wochenschr
1986 ; 111 : 921 –2
6.
Sebban
C
,
Lasne
Y
,
Berenguer
V
,
Archimbaud
E
,
Decaux
Y
,
Viala
JJ
. CA 125 and malignant lymphomas . J Clin Oncol
1991 ; 9 : 359 –60
7.
Apel
RL
,
Fernandes
SJ
. Malignant lymphoma presenting with an elevated serum CA-125 level . Arch Pathol Lab Med
1995 ; 119 : 373 –6
8.
Benboubker
L
,
Linassier
C
,
Ollivier
I
,
Delain
M
,
Valat
C
,
Fetissof
F.
S-CA 125 and LDH levels as a new prognostic index in patients with non-Hodgkin's lymphomas . Blood
1996 ; 88 (suppl 1 ): 224a
9.
Lazzarino
M
,
Orlandi
E
,
Klersy
C
,
Astori
C
,
Brusamolino
E
,
Corso
A.
Serum CA-125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity . Cancer
1998 ; 82 : 576 –82
10.
Kubonishi
I
,
Bandobashi
K
,
Murata
N
,
Daibata
M
,
Ido
E
,
Sonobe
H.
High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma . Br J Haematol
1997 ; 98 : 450 –2
11.
Harris
NL
,
Jaffe
ES
,
Stein
H
,
Banks
PM
,
Chan
JKC
,
Cleary
ML
. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group . Blood
1994 ; 84 : 1361 –92
12.
De Mascarel
A
,
Merlio
IP
,
Coindre
JM
,
Goussot
JF
,
Broustet
A.
A gastric large cell lymphoma expressing cytokeratin but no leucocyte common antigen. A diagnostic dilemma . Am J Clin Pathol
1989 ; 91 : 478 –81
